
|Slideshows|September 27, 2018
Inhaled Steroids Increase Risk of Nontuberculous Mycobacteria Lung Infections
Author(s)Mark L. Fuerst
When using inhaled corticosteroids for the treatment of asthma, COPD, and other airways disease, authors of a new study warn to proceed with caution.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes
2
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
3
FDA OKs Subcutaneous Guselkumab Regimen for Ulcerative Colitis: Daily Dose
4
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment
5